Olga Zapletalová
- Pharmacology top 5%
- Neurology top 5%
- Peripheral Neuropathies and Disorders 3
- Botulinum Toxin and Related Neurological Disorders 3
- Cerebral Venous Sinus Thrombosis 2
-
- Multiple Sclerosis Research Studies 11
- Systemic Sclerosis and Related Diseases 2
- Toxicology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Retinal and Optic Conditions 2
-
- Systemic Lupus Erythematosus Research 2
- Co-authors
- Zdeněk AmblerS. RatcliffePaul DaviesIveta NovákováPavel HradílekDavid ZemanPavlína KušnierováMarta Vachová
- Partner nations
- CzechiaSlovakiaUnited Kingdom
In The Last Decade
Olga Zapletalová
21 papers receiving 707 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 345
- Neurology 260
- Pathology and Forensic Medicine 307
- Toxicology 34
- Cellular and Molecular Neuroscience 107
Countries citing papers authored by Olga Zapletalová
This map shows the geographic impact of Olga Zapletalová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Zapletalová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Zapletalová more than expected).
Fields of papers citing papers by Olga Zapletalová
This network shows the impact of papers produced by Olga Zapletalová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Zapletalová. The network helps show where Olga Zapletalová may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olga Zapletalová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 4 | |
| 2 | 2020 | 7 | |
| 3 | 2020 | 28 | |
| 4 | 2019 | 31 | |
| 5 | 2016 | 24 | |
| 6 | 2016 | 1 | |
| 7 | 2016 | 0 | |
| 8 | 2015 | 13 | |
| 9 | 2014 | 17 | |
| 10 | Klinický standard pro diagnostiku a léčbu myasthenia gravis | 2012 | 1 |
| 11 | 2012 | 8 | |
| 12 | 2012 | 3 | |
| 13 | 2011 | 313 | |
| 14 | 2010 | 209 | |
| 15 | 2009 | 19 | |
| 16 | Výsledky léčby neurogenních dysfunkcí dolních cest močových aplikací botulinumtoxinu do detruzoru | 2007 | 1 |
| 17 | 2007 | 45 | |
| 18 | 2007 | 15 | |
| 19 | [Pregnancy and multiple sclerosis]. | 2005 | 1 |
| 20 | Neurologické komplikace protinádorové léčby | 2003 | 0 |
About Olga Zapletalová
Olga Zapletalová is a scholar working on Neurology, Pathology and Forensic Medicine and Internal Medicine, having authored 26 papers that have together received 751 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (11 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Peripheral Neuropathies and Disorders (3 papers), Botulinum Toxin and Related Neurological Disorders (3 papers), Systemic Sclerosis and Related Diseases (2 papers), Cerebral Venous Sinus Thrombosis (2 papers), Retinal and Optic Conditions (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Pharmacology (345 citations), Neurology (260 citations) and Pathology and Forensic Medicine (307 citations). Olga Zapletalová has collaborated with scholars based in Czechia, Slovakia and United Kingdom. Frequent co-authors include Zdeněk Ambler, S. Ratcliffe, Paul Davies, Iveta Nováková, Pavel Hradílek, David Zeman, Pavlína Kušnierová, Marta Vachová, Jan Mareš and Claudio Gasperini. Their work appears in journals such as PLoS ONE, Neurology and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.